Dose response in the treatment of breast cancer
- 12 February 1994
- journal article
- viewpoint
- Published by Elsevier in The Lancet
- Vol. 343 (8894) , 402-404
- https://doi.org/10.1016/s0140-6736(94)91229-7
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Regulation of surface‐differentiation molecules by epidermal growth factor, transforming growth factor alpha, and hydrocortisone in human mammary epithelial cells transformed by an activated c‐Ha‐ras proto‐oncogeneInternational Journal of Cancer, 1992
- Cytokines and Growth Factors in the Pathogenesis of AIDS‐Associated Kaposi's SarcomaImmunological Reviews, 1992
- The origin and function of tumor-associated macrophagesImmunology Today, 1992
- Effects of cyclosporine on immunologic mechanisms in psoriasisJournal of the American Academy of Dermatology, 1990
- Glucocorticoids inhibit the production of IL 6 from monocytes, endothelial cells and fibroblastsEuropean Journal of Immunology, 1990
- Immunohistochemical distribution of c‐erbB‐2 in in situ breast carcinoma—a detailed morphological analysisThe Journal of Pathology, 1990
- ALTERED IMMUNOLOGIC RECONSTITUTION AFTER STANDARD-DOSE CHEMOTHERAPY OR HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE MARROW SUPPORTTransplantation, 1988
- EVIDENCE FOR AN EFFECT OF ANTITHYROID DRUGS ON THE NATURAL HISTORY OF GRAVES' DISEASEClinical Endocrinology, 1984
- T‐Cell Growth FactorImmunological Reviews, 1980
- Corticosteroids in Therapy of Advanced Mammary CancerBMJ, 1963